|
May 5
|
Analyst Estimates: Here's What Brokers Think Of iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its First-Quarter Report
|
|
May 5
|
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Q1 2024 iRhythm Technologies Inc Earnings Call
|
|
May 2
|
iRhythm Technologies Reports Q1 2024 Results: Revenue Surpasses Estimates Amidst Wider Losses
|
|
May 2
|
iRhythm Technologies Announces First Quarter 2024 Financial Results
|
|
Apr 23
|
What Makes iRhythm Technologies (IRTC) a Lucrative Investment?
|
|
Apr 18
|
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
|
|
Apr 8
|
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
|
|
Apr 5
|
Loss-Making iRhythm Technologies, Inc. (NASDAQ:IRTC) Expected To Breakeven In The Medium-Term
|
|
Mar 8
|
iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
|
|
Mar 6
|
Insider Sell: EVP, CMO & CSO Minang Turakhia Sells 943 Shares of iRhythm Technologies Inc (IRTC)
|
|
Mar 5
|
iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
|
|
Mar 4
|
iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes
|
|
Jan 11
|
At US$112, Is iRhythm Technologies, Inc. (NASDAQ:IRTC) Worth Looking At Closely?
|
|
Jan 8
|
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Jan 5
|
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
|
|
Jan 5
|
iRhythm Technologies Inc Insider Sells Company Shares
|
|
Dec 26
|
iRhythm Technologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Aug 29
|
iRhythm Technologies to Participate in Two Investor Conferences in September
|